Nature - Issue - nature.com science feeds

VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

Nature, Published online: 19 March 2025; doi:10.1038/s41586-025-08732-6VDAC2 deficiency elicits uncontrolled IFNγ-induced BAK activation and mitochondrial damage for improved cancer therapy.

Mar 19, 2025 - 17:45
 0
VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

Nature, Published online: 19 March 2025; doi:10.1038/s41586-025-08732-6VDAC2 deficiency elicits uncontrolled IFNγ-induced BAK activation and mitochondrial damage for improved cancer therapy.

Read More

Tags:

Previous Article

A polyene macrolide targeting phospholipids in the fungal cell membrane

Next Article

Drivers of avian genomic change revealed by evolutionary rate decomposition

Related Posts

US science is under threat ― now scientists are fighting back

US science is under threat ― now scientists are fightin...

Mar 3, 2025  0

Integrated analysis of the complete sequence of a macaque genome

Integrated analysis of the complete sequence of a macaq...

Feb 26, 2025  0

Global modules robustly emerge from local interactions and smooth gradients

Global modules robustly emerge from local interactions ...

Feb 19, 2025  0